FDA approves AtriCure's Synergy cardiac ablation device

December 16, 2011 by MassDevice staff

AtriCure gets a modest bump on Wall Street after the FDA OK's its Synergy radiofrequency device, the first cardiac ablation device approved for treating atrial fibrillation in the U.S.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp